Evidently, as a key protein kinase at the crossroad of AGC signaling pathways, PDK1 is inevitably a promising target with multiple roles in BC, particularly for those tumors with aggressiveness, metastasization, and chemoresistance. The gene discussed is PDK1; the disease is breast cancer.